SOL Capital Management’s Novartis NVS Stock Holding History

SOL Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,077	Closed	-$314K	–	246
2017 Q3	$314K	Hold	4,077	–	–	0.09%	202
2017 Q2	$305K	Hold	4,077	–	–	0.08%	203
2017 Q1	$271K	Sell	4,077 -939	-19%	-$62.6K	0.08%	204
2016 Q4	$327K	Hold	5,016	–	–	0.1%	182
2016 Q3	$355K	Hold	5,016	–	–	0.12%	154
2016 Q2	$371K	Buy	5,016 +111	+2%	+$7.67K	0.12%	142
2016 Q1	$318K	Hold	4,905	–	–	0.11%	152
2015 Q4	$378K	Hold	4,905	–	–	0.13%	141
2015 Q3	$404K	Hold	4,905	–	–	0.16%	135
2015 Q2	$432K	Hold	4,905	–	–	0.16%	126
2015 Q1	$433K	Hold	4,905	–	–	0.16%	127
2014 Q4	$407K	Hold	4,905	–	–	0.16%	124
2014 Q3	$414K	Sell	4,905 -310	-6%	-$25.1K	0.17%	120
2014 Q2	$423K	Hold	5,215	–	–	0.17%	119
2014 Q1	$397K	Sell	5,215 -251	-5%	-$18.3K	0.16%	122
2013 Q4	$394K	Sell	5,466 -112	-2%	-$7.79K	0.15%	119
2013 Q3	$383K	Buy	5,578 +134	+2%	+$8.87K	0.16%	119
2013 Q2	$345K	Buy	+5,444	New	+$354K	0.14%	124

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SOL Capital Management's NVS Position: Q4 2017 in Review

SOL Capital Management sold out of Novartis (NVS) in Q4 2017, closing a stake of 4,077 shares — an estimated $314K sold.

SOL Capital Management first reported a position in NVS in Q2 2013 and held it in 18 quarters. The position peaked at $433K in Q1 2015. 1,007 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

SOL Capital Management reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
SOL Capital Management sold 4,077 Novartis shares in Q4 2017, an estimated $314K.
SOL Capital Management first reported a position in Novartis in Q2 2013 and held it in 18 quarters.
SOL Capital Management's Novartis position peaked at $433K in Q1 2015.
1,007 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on SOL Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.